The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor
- 1 April 1992
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 14 (3) , 505-510
- https://doi.org/10.1016/0192-0561(92)90182-k
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Selective 5-lipoxygenase inhibition in ulcerative colitisThe Lancet, 1990
- Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesisJournal of Medicinal Chemistry, 1988
- Orally active hydroxamic acid inhibitors of leukotriene biosynthesisJournal of Medicinal Chemistry, 1988
- Synthesis and 5-lipoxygenase inhibitory activity of 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid analogsJournal of Medicinal Chemistry, 1987
- Differential Effects of Anti-Inflammatory Drugs on Fluid Accumulation and Cellular Infiltration in Reverse Passive Arthus Pleurisy and Carrageenan Pleurisy in RatsPharmacology, 1987
- Rationally designed, potent competitive inhibitors of leukotriene biosynthesisJournal of the American Chemical Society, 1984
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Selective inhibition of platelet lipoxygenase by baicaleinBiochemical and Biophysical Research Communications, 1982
- Vitamin E modulates the lipoxygenation of arachidonic acid in leukocytesNature, 1980
- Calcium stimulation of a novel lipoxygenaseBiochemical and Biophysical Research Communications, 1980